1. Home
  2. VRSK vs DGX Comparison

VRSK vs DGX Comparison

Compare VRSK & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verisk Analytics Inc.

VRSK

Verisk Analytics Inc.

HOLD

Current Price

$183.42

Market Cap

24.0B

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$203.50

Market Cap

22.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRSK
DGX
Founded
1971
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.0B
22.6B
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
VRSK
DGX
Price
$183.42
$203.50
Analyst Decision
Buy
Buy
Analyst Count
13
13
Target Price
$259.38
$214.38
AVG Volume (30 Days)
1.8M
653.1K
Earning Date
04-29-2026
04-21-2026
Dividend Yield
1.06%
1.82%
EPS Growth
N/A
13.78
EPS
1.73
2.24
Revenue
N/A
$11,035,000,000.00
Revenue This Year
$6.68
$7.53
Revenue Next Year
$6.74
$3.77
P/E Ratio
$105.21
$90.89
Revenue Growth
N/A
11.78
52 Week Low
$155.94
$164.65
52 Week High
$314.80
$213.50

Technical Indicators

Market Signals
Indicator
VRSK
DGX
Relative Strength Index (RSI) 58.39 62.38
Support Level $160.75 $200.94
Resistance Level $191.51 $205.00
Average True Range (ATR) 5.70 4.21
MACD 1.12 1.19
Stochastic Oscillator 88.92 73.13

Price Performance

Historical Comparison
VRSK
DGX

About VRSK Verisk Analytics Inc.

Verisk is a leading data, analytics, and technology provider for property-casualty insurers. Verisk traces its history to Insurance Services Office, a nonprofit advisory organization founded in 1971 by US P&C insurers. ISO was formed as an association of insurance companies to assist with a variety of insurance use cases, such as reporting to regulators, defining policies, and determining independent premium rates. As the firm expanded its use cases, it became a for-profit company, renamed Verisk, and went public in 2009. Verisk's single segment (insurance) provides underwriting solutions, including forms, rules, loss costs, and catastrophe modeling. For claims, Verisk's solutions include property repair estimates and antifraud tools. About 83% of Verisk's revenue is US-based.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: